On February 1st, during CalABA’s 2019 conference in Long Beach, Gateway’s CEO, Melissa Willa, will lead a panel discussion on the topic of “Treatment Planning: Dosage, Duration, and Discharge”. Melissa will be joined by Dr. Bryna Siegel, Executive Director of the Autism Center of Northern California, Dr. Linda Haymes, Associate Professor/Chair Special Education at Touro University, and Yagnesh Vadgama, Sr. Director of Clinical Care Services at Magellan Health.
Similar Articles
For Parents
Understanding Co-Occurring Diagnoses with Autism
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects how a person communicates, interacts socially, and processes the...
READ
For Parents
Is ABA Right for My Child with Autism? A Parent-Friendly Guide
If you’re raising a child with autism, you may find that deciding on the right support and therapies can...
READ
For Parents
How to Navigate Insurance Coverage for ABA Therapy: A Comprehensive Guide
Applied Behavior Analysis (ABA) therapy is a highly effective, intensive treatment for children with autism. ABA therapy is typically...
READ